Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @SQZBiotech
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @SQZBiotech
-
Today is
#WorldCancerDay
. At SQZ, we are committed to our work developing targeted cell therapies to potentially address numerous #cancer types. Learn more about our first clinical trial focused on#HPV+ solid tumors: http://bit.ly/2GUij5O pic.twitter.com/wF458hdhVO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As many as 93% of
#CervicalCancers could be prevented by screening &#HPV vaccination. Yet, in 2012, 8 million U.S. women ages 21 to 65 reported they had not been screened for cervical cancer in the last 5 years. Learn more about screening options here: http://bit.ly/2RNTX3X pic.twitter.com/0AmVTgzxDi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are excited to announce that the first patient in the Ph1
#ClinicalTrial evaluating our autologous#CellTherapy comprised of SQZ-engineered APCs for HPV+ tumors has started treatment. Click here to read more about this pivotal company milestone: http://bit.ly/36HUHeS pic.twitter.com/Scuxk4tgz4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This month we are recognizing SQZ
#BoardOfDirectors member, Pushkal Garg, MD. Dr. Garg is the chief medical officer at@Alnylam & brings 2 decades of experience in#clinical drug development to the SQZ BoD. Learn more about the exceptional SQZ board here: http://bit.ly/3aOKb91 pic.twitter.com/cMHYfvKidW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
SQZ AACs have the potential to address multiple
#oncology indications. Learn more about AACs and their unique mechanism of action here: http://bit.ly/2ur9eyl pic.twitter.com/x7J34OlivV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today's
@biospace article by@AlexKeown previews what is to come in 2020 from SQZ! 2020 is a big year with progress in our SQZ APC clinical trial for the treatment of HPV+ solid tumors & more advances developing our AAC immunotherapy program for#oncology:https://bit.ly/2Gg75rSHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Some types of
#HPV are linked to cervical cell changes that, if not detected early, can increase a woman’s risk for#CervicalCancer. Learn 10 facts about#HPV &#CervicalCancer from@StopHPVCancer: http://bit.ly/2TAC9dx#CervicalHealthAwarenessMonthpic.twitter.com/yDszFrNdOo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are at
#JPM20 in San Francisco this week! We look forward to connecting with the#biotech community and discussing our#CellTherapy platform that has the potential to be broadly applicable across many diseases.pic.twitter.com/hwIlPAczBB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tomorrow, SQZ CEO, Armon Sharei, will participate in the @LifeSci_PR
#JPM20 panel led by@FierceBiotech’s@amirahalidrus. Armon & other#biotech CEOs will discuss leveraging new technologies to tackle prevalent conditions. Interested in attending? RSVP: http://bit.ly/2sgnEjV pic.twitter.com/jrOHsU84KV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are developing
#CellTherapies for#oncology indications using two different approaches to stimulate antigen-specific immune activation for the treatment of#SolidTumors. Learn more about our cell engineering platform: http://bit.ly/2ukvcTo pic.twitter.com/5tcBBmFsGS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
January is
#CervicalHealthAwarenessMonth.#DYK that 13,000 women in the U.S. are diagnosed with#CervicalCancer each year? We are currently recruiting patients with HPV+ cervical cancer for our Ph. 1 clinical trial. Learn more here: http://bit.ly/36qhIDS pic.twitter.com/KkqAyXR6O6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK that HPV+ tumors represent about 5% of cancers worldwide? Click here to learn more about SQZ’s first clinical trial focused on therapies to treat HPV+ solid tumors: http://bit.ly/2thoFbO pic.twitter.com/zgbyY9D3Yc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We recently announced our proprietary cell therapy approach to
#oncology, SQZ AACs. The aim of the program is to leverage the mechanisms of endogenous APCs, using red blood cells to deliver antigen and prime T cell response against#tumors. Read more http://bit.ly/2r1l0Ox pic.twitter.com/YwgdFX2sNW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This month we are recognizing SQZ
#BoardOfDirectors member, Zafi Avnur. Zafi currently serves as CSO at Quark Venture & was a champion for the SQZ &@Roche partnership while she served as Global Head of Academic Innovation at Roche. Learn more: http://bit.ly/2PzPY8D pic.twitter.com/FCs9B58H0K
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK that head & neck cancers account for approx. 4% of all cancers in the U.S. & are more than twice as common among men than women? SQZ’s first clinical program focuses on HPV+ tumors, including#HeadAndNeck. Learn more about our Phase 1 trial here: http://bit.ly/33W4Seq pic.twitter.com/2TBa9z3IYz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tomorrow, SQZ will be presenting at the
#Evercore ISI HEALTHCONx Conference at 9:30 am ET. Click here for presentation details: http://bit.ly/2LfwRPK pic.twitter.com/NcQt6Hzhzw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Happy
#Thanksgiving from your friends at SQZ! Today and every day we are#thankful for the opportunity to develop cell therapies with the potential to impact patients suffering from a range of diseases.
pic.twitter.com/ANkiG166ey
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK that#HumanPapillomavirus can cause several different types of#cancer? Visit@NIH website to learn more about#HPV: http://bit.ly/2Ol5iGQ pic.twitter.com/Ak0nkBp52j
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marc Elia, a member of our BoD since 2018, has over 20 years’ experience in biotech, including as founder of M28 Capital Management. He is passionate about SQZ & eager to see our team assess the impact of large-scale antigen presentation in cancer. http://bit.ly/2DgkDSA pic.twitter.com/gmqNnbwtJo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
SQZ CEO Armon Sharei was featured in
@WuXi_AppTec discussing the exciting potential of the SQZ platform, our recent evolution into a#clinicalstage company developing therapies for patients & key themes in the#cell and#gene#therapy space. Check it out!http://bit.ly/34avmtOHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.